title: [Pseudohyperaldosteronism by chronic overdose of "Pulmoll" expectorant lozenges].
authors.forename: H
authors.initials: H
authors.lastname: Lévesque
authors.forename: N
authors.initials: N
authors.lastname: Cailleux
authors.forename: J R
authors.initials: JR
authors.lastname: Poutrain
authors.forename: C
authors.initials: C
authors.lastname: Noblet
authors.forename: N
authors.initials: N
authors.lastname: Moore
authors.forename: H
authors.initials: H
authors.lastname: Courtois
mesh_terms: D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002908:Chronic Disease; D062787:Drug Overdose / Q000150:complications; D005100:Expectorants / Q000009:adverse effects*; D006034:Glycyrrhetinic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D019695:Glycyrrhizic Acid; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D008297:Male; D013607:Tablets
chemical_list: D000890:Anti-Infective Agents; D005100:Expectorants; D013607:Tablets; D019695:Glycyrrhizic Acid; D006034:Glycyrrhetinic Acid
vernacular_title: Pseudohyperaldostéronisme par surdosage chronique en pastilles "Pulmoll" marron.